SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors - Kratochwil, C.; Stefanova, M.; Mavriopoulou, E.; Holland-Letz, T.; Dimitrakopoulou-Strauss, A.; Afshar-Oromieh, A.; Mier, W.; Haberkorn, U.; Giesel, F. L. (Molecular imaging and biology, 2015)
Keywords: Aged; Brief Article; Contrast Media; Female; Humans; Imaging; Liver Neoplasms - diagnostic imaging; Liver Neoplasms - pathology; Liver Neoplasms - secondary; Male; Medicine; Medicine & Public Health; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors - diagnostic imaging; Octreotide - analogs & derivatives; Octreotide - chemistry; Organometallic Compounds - chemistry; Peptides - chemistry; Positron-Emission Tomography; Probability; Radiology; Radiopharmaceuticals - chemistry; Receptors, Somatostatin - chemistry; Receptors, Somatostatin - metabolism; ROC Curve; Tomography, X-Ray Computed; Peptide-related radionuclide therapy; Ga]DOTATOC; Somatostatin receptor; [; SUV; Neuroendocrine tumors